PathWhiz ID | Pathway | Meta Data |
---|---|---|
PW145950View Pathway |
drug action
Trimetazidine Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 17:02 Last Updated: October 07, 2023 at 17:02 |
PW127933View Pathway |
drug action
Trimethadione Action PathwayHomo sapiens
Trimethadione is an anticonvulsant agent indicated for the control of treatment-refractory petit mal seizures. An anticonvulsant effective in absence seizures, but generally reserved for refractory cases because of its toxicity. Paramethadione and trimethadione are anticonvulsants indicated in the control of absence (petit mal) seizures that are refractory to treatment with other medications. Dione anticonvulsants are used in the treatment of epilepsy. They act on the central nervous system (CNS) to reduce the number of seizures. Dione anticonvulsants reduce T-type calcium currents in thalamic neurons, including thalamic relay neurons. It does so via the inhibition of voltage dependent T-type calcium channels. This raises the threshold for repetitive activity in the thalamus, and inhibits corticothalamic transmission. Thus, the abnormal thalamocortical rhythmicity, which is thought to underlie the 3-Hz spike-and-wave discharge seen on electroencephalogram(EEG) with absence seizures, is dampened. GABA release is inhibited due to mutations of the SCN1A, SCN1B gene causing enhanced reuptake. Possible side effects of using trimethadione may include tiredness, changes in weight, hiccups, and headache.
|
Creator: Hayley Created On: June 20, 2023 at 14:03 Last Updated: June 20, 2023 at 14:03 |
PW144473View Pathway |
drug action
Trimethadione Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 13:42 Last Updated: October 07, 2023 at 13:42 |
PW176157View Pathway |
Trimethadione Predicted Metabolism Pathway newHomo sapiens
Metabolites of Trimethadione are predicted with biotransformer.
|
Creator: Omolola Created On: November 29, 2023 at 14:23 Last Updated: November 29, 2023 at 14:23 |
PW145205View Pathway |
drug action
Trimethaphan Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 15:18 Last Updated: October 07, 2023 at 15:18 |
PW144775View Pathway |
drug action
Trimethobenzamide Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 14:24 Last Updated: October 07, 2023 at 14:24 |
PW144565View Pathway |
drug action
Trimethoprim Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 13:54 Last Updated: October 07, 2023 at 13:54 |
PW176444View Pathway |
Trimethoprim Predicted Metabolism PathwayHomo sapiens
Metabolites of Trimethoprim are predicted with biotransformer.
|
Creator: Omolola Created On: December 12, 2023 at 12:55 Last Updated: December 12, 2023 at 12:55 |
PW145245View Pathway |
drug action
Trimetrexate Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 15:24 Last Updated: October 07, 2023 at 15:24 |
PW127943View Pathway |
drug action
Trimipramine Action PathwayHomo sapiens
Trimipramine is a tricyclic antidepressant (TCA) used to treat depression accompanied or not by anxiety and agitation or sleep disturbance. It is very similar to imipramine but it has more antihistaminic and sedative properties. Trimipramine acts by decreasing the reuptake of norepinephrine and serotonin (5-HT) in the neurons. By binding to the sodium-dependent serotonin transporter and the sodium-dependent noradrenaline transporter, trimipramine fulfill its functions. Some side effects of its use include agitation, convulsions, irregular heart rate, muscle rigidity, stupor, and some others. This drug is administered as an oral tablet.
|
Creator: Daphnee Created On: June 21, 2023 at 12:58 Last Updated: June 21, 2023 at 12:58 |